| Previous Close | 5.33 |
| Open | 5.33 |
| Bid | 5.16 x 1000 |
| Ask | 6.28 x 100 |
| Day's Range | 5.27 - 5.47 |
| 52 Week Range | 0.19 - 6.60 |
| Volume | 82,577 |
| Avg. Volume | 102,719 |
| Market Cap | 64.99M |
| Beta | 1.62 |
| PE Ratio (TTM) | -2.30 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Capital Cube•16 days ago
ETFs with exposure to Neuralstem, Inc. : July 4, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Neuralstem, Inc. Here are 5 ETFs with the largest exposure to CUR-US. Comparing the performance and risk of Neuralstem, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- Capital Cube•2 months ago
ETFs with exposure to Neuralstem, Inc. : June 2, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Neuralstem, Inc. Here are 5 ETFs with the largest exposure to CUR-US. Comparing the performance and risk of Neuralstem, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube•2 months agoNeuralstem, Inc. :CUR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017
Categories: Yahoo FinanceGet free summary analysis Neuralstem, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Neuralstem, Inc. – Titan Pharmaceuticals, Inc., Cytokinetics, Incorporated, Acorda Therapeutics, Inc., Geron Corporation, Neurocrine Biosciences, Inc., Albany Molecular Research, Inc., Aceto Corporation, BioTime, Inc., Charles River Laboratories International, Inc. ... Read more (Read more...)
